Sponsor Pipeline

WestVac Biopharma Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
1
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT05911048
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9…
overall status: Not Yet Recruiting → Unknown
2026-08-02 NCT05911061
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein…
overall status: Not Yet Recruiting → Unknown
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07170800 A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets Tuberculosis Recruiting
Phase 1
NCT07462468 A Phase 1 Clinical Study to Evaluate the Safety and Efficacy of WSK-IM02 in Patients With… Platinum-resistant Recurrent Ovarian Cancer (PROC) Not Yet Recruiting
NCT07615894 WSK-IM02 in Advanced Solid Tumors With Malignant Effusions (Phase I) Advanced Solid Tumors Not Yet Recruiting
Disease Areas
Get alerts when WestVac Biopharma Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free